All our News

In 2022, Provepharm reached an important milestone in its CSR strategy. In this "2023 CSR Impact", the essential elements of our approach have been grouped together.

Provepharm, an international, private and sustainable pharmaceutical company specialized in revitalizing molecules and Pharm-D, a healthcare and pharmaceutical company based in Malaysia with a strong foothold in Singapore, announce today their partnership to launch Proveblue® 5 mg/ml solution for injection in Malaysia.

We are pleased to present our latest Corporate film.

On Tuesday July 18, 2023, the 140 Provepharm employees, some of whom came from the USA and the UK, celebrated the quarter century of the pharmaceutical laboratory in an emblematic place in Marseille, Casa Delauze.

The 18th annual event of ETPN & the 5th ENM conference merged into a unique event: #NME23 

At Provepharm Life Solutions, we innovate to realize each molecule's full potential, to provide treatments that help improve patients' lives.


All Provepharm Life Solutions employees wish you happy holidays and All the Best for 2023.

Discover our wishes in video!


You are about to leave the Provepharm Corporate website. If you continue you will reach the website of our US subsidiary which the information is not necessarily applicable to France.